After a sharp decline spooked investors, AeroVironment’s stock has rebounded strongly in today’s trading. The volatility stems from ongoing renegotiations of a multi-billion dollar contract with the U.S. Space Force. While uncertainty around the prestigious SCAR program fueled recent swings, new corporate communications suggest a potential resolution is being forged.
Operational Growth Amidst Negotiations
Beyond the high-stakes contract discussions, the drone specialist continues to expand its operational footprint. The company is investing $30 million to scale up manufacturing capacity for space components and directed energy systems at its facility in Albuquerque, New Mexico. This expansion is supported by robust financials: quarterly revenue recently surged by 151 percent. Furthermore, a separate $186 million order from the U.S. Army for Switchblade loitering munitions underscores ongoing demand for the company’s core products.
The recent investor anxiety was triggered by reports that the U.S. Space Force might reopen the bidding process for the “Satellite Communications Augmentation Resource” (SCAR) program. This initiative, which AeroVironment acquired through its purchase of BlueHalo, carries an estimated total value between $1.4 and $1.7 billion. The mere prospect of losing this substantial award sent the equity into a downward spiral earlier this week.
Should investors sell immediately? Or is it worth buying AeroVironment?
Management has now confirmed that active discussions are underway to modify the existing agreement. The goal is to transition the contract to a fixed-price structure with an accelerated delivery timeline. Although a work stoppage on certain program elements has been in place since January 2026, the confirmation of productive negotiations has calmed market nerves. The relief was palpable: shares are currently trading at 196.45 Euros, marking a significant single-day gain of 10.30 percent.
Analyst Perspectives and Forward Calendar
Market experts have offered a mixed, yet largely measured, response to the SCAR developments. Several firms, including RBC Capital and Robert W. Baird, adjusted their price targets downward but predominantly maintained their positive ratings on the stock. Analysts at BTIG provided crucial context, noting that the SCAR program in question currently contributes only about 6 percent to the company’s annual revenue, a figure that helps temper the perceived risk.
For shareholders, the focus now shifts to March 10, 2026. On this date, AeroVironment is scheduled to release its third-quarter financial results. The accompanying conference call will be a critical venue for management to demonstrate that its broader growth strategy remains on track, despite the current administrative hurdles surrounding this single, albeit significant, government contract.
Ad
AeroVironment Stock: Buy or Sell?! New AeroVironment Analysis from March 4 delivers the answer:
The latest AeroVironment figures speak for themselves: Urgent action needed for AeroVironment investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 4.
AeroVironment: Buy or sell? Read more here...
